Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update

21Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Type 2 diabetes mellitus (T2DM) is an epidemic with an ever-increasing global prevalence. Current treatment strategies, although plentiful and somewhat effective, often fail to achieve desired glycaemic goals in many people, leading ultimately to disease complications. The lack of sustained efficacy of clinically-approved drugs has led to a heightened interest in the development of novel alternative efficacious antidiabetic therapies. One potential option in this regard is the peptide apelin, an adipokine that acts as an endogenous ligand of the APJ receptor. Apelin exists in various molecular isoforms and was initially studied for its cardiovascular benefits, however recent research suggests that it also plays a key role in glycaemic control. As such, apelin peptides have been shown to improve insulin sensitivity, glucose tolerance and lower circulating blood glucose. Nevertheless, native apelin has a short biological half-life that limits its therapeutic potential. More recently, analogues of apelin, particularly apelin-13, have been developed that possess a significantly extended biological half-life. These analogues may represent a promising target for future development of therapies for metabolic disease including diabetes and obesity.

References Powered by Scopus

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9<sup>th</sup> edition

7108Citations
N/AReaders
Get full text

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

3823Citations
N/AReaders
Get full text

Mechanisms of diabetic complications

2037Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Targeting the apelin system for the treatment of cardiovascular diseases

32Citations
N/AReaders
Get full text

Molecular communication between Apelin-13, Apelin-36, Elabela, and nitric oxide in gestational diabetes mellitus

11Citations
N/AReaders
Get full text

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure

8Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Palmer, E. S., Irwin, N., & O’Harte, F. P. M. (2022, February 1). Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update. Clinical Medicine Insights: Endocrinology and Diabetes. SAGE Publications Ltd. https://doi.org/10.1177/11795514221074679

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

46%

Researcher 4

31%

Professor / Associate Prof. 2

15%

Lecturer / Post doc 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

46%

Biochemistry, Genetics and Molecular Bi... 3

23%

Pharmacology, Toxicology and Pharmaceut... 2

15%

Nursing and Health Professions 2

15%

Save time finding and organizing research with Mendeley

Sign up for free